about
Zinc and zinc transporters in macrophages and their roles in efferocytosis in COPDRegulation of CRIg expression and phagocytosis in human macrophages by arachidonate, dexamethasone, and cytokinesLectins offer new perspectives in the development of macrophage-targeted therapies for COPD/emphysema.Inhibition of the lipopolysaccharide-induced stimulation of the members of the MAPK family in human monocytes/macrophages by 4-hydroxynonenal, a product of oxidized omega-6 fatty acids.Airway clearance of apoptotic cells in COPD.Cancer diagnosed in the Emergency Department of a Regional Health Service.Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response.Evaluating the role of Magnetic Resonance Imaging post Neoadjuvant Therapy for Breast Cancer in the NEONAB trial.Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation.Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary diseaseTailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of responseRegulation of neutrophil-mediated killing of Staphylococcus aureus and chemotaxis by c-jun NH2 terminal kinaseCigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine
P50
Q34414431-17A22D46-BD73-4E25-92CC-2745DF603894Q35167899-9AE3293F-99B7-4FE1-8941-FF355F74952CQ36618671-5AF5F6F2-FF6B-40A2-8522-AF346B4C8BBEQ36891522-D5A02972-F4E1-4417-9316-9498AA18A0C3Q37745095-C2ED413E-62E0-49E9-B572-3475F8ACA14FQ40034609-8827A9F0-1F34-4E40-827C-86FE0658D403Q44553005-528E9C0D-2ED5-41EA-A804-C022BB3E596EQ45069674-E0958302-9987-43E4-9AC8-4A17CFE2BD87Q48132715-86DD6A7A-4B76-40F2-A667-DFFC86249605Q53070035-61D9A309-BD3E-4B5F-BB36-B1A64E9E9DB3Q56898555-E5BB273C-F90A-490D-AEB0-65EC278FA3E8Q64243646-DE6AE9A0-742C-419B-9E55-15ACF4E84481Q82630708-BB59492B-348C-439E-A8BE-7276E5C254BCQ84512676-2B6B0778-E573-473E-BFD0-E7EBADE2385D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Violet Mukaro
@en
Violet Mukaro
@nl
type
label
Violet Mukaro
@en
Violet Mukaro
@nl
prefLabel
Violet Mukaro
@en
Violet Mukaro
@nl
P31
P496
0000-0002-3968-6551